黄芪合丹参注射液治疗老年退行性心脏瓣膜病心功能不全

探讨黄芪注射液合丹参注射液对老年退行性心脏瓣膜病心功能不全的治疗作用。将60例退行性心脏瓣膜病伴心功能不全患者随机分为2组，治疗组在洋地黄、利尿剂和血管扩张剂常规治疗的基础上加用黄芪注射液和丹参注射液静脉滴注，对照组给常规治疗，2组均连续用药2周。结果：治疗组总有效率96．7％，对照组73．3％：治疗组治疗后，患者心排量、心脏指数和射血分数均明显增加，与治疗前及对照组比较有显著性差异。治疗组治疗期间未见不良反应。结论：黄芪注射液合丹参注射液静脉滴注是治疗老年退行性心脏瓣膜病心功能不全的有效而安全的药物。

Senile Degenerative Cardiac Valvular Disease with Cardiacinsufficiency Treated by Huangqi & Danshen Injection

To explore the therapeutic effect of huangqi injection and danshen injection for senile degenerative cardiac valvular disease with cardiacinsufficiency. 60 cases were divided randomly two groups, the therapeutic group were given huangqi and danshen injection by intravenous drip based on conventional therapy for two weeks, while contrast group were only given conventional therapy. Result: The total effective rate of the therapeutic group was 96.7%, and contrast group 3.3%(P<0.05). The cardiac output, cardiac index, and ejection fraction in the therapeutic group had obviously increased, there was a significant difference compared with contrast group, and there was no adverse reaction during therapy. Conclusion: Huangqi and danshen injection are effective and safe drugs for senile degenerative cardiac valvular disease with cardiacinsufficiency.